• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血系统与免疫系统的交汇点:相互作用与关联。

The Crossroads of the Coagulation System and the Immune System: Interactions and Connections.

机构信息

Department of Plastic and Reconstructive Surgery and Microsurgery, Medical University of Lublin, 20-059 Lublin, Poland.

Department of Experimental Immunology, Medical University of Lublin, 20-093 Lublin, Poland.

出版信息

Int J Mol Sci. 2023 Aug 8;24(16):12563. doi: 10.3390/ijms241612563.

DOI:10.3390/ijms241612563
PMID:37628744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10454528/
Abstract

The coagulation and immune systems, two vital systems in the human body, share intimate connections that fundamentally determine patient health. These systems work together through several common regulatory pathways, including the Tissue Factor (TF) Pathway. Immune cells expressing TF and producing pro-inflammatory cytokines can influence coagulation, while coagulation factors and processes reciprocally impact immune responses by activating immune cells and controlling their functions. These shared pathways contribute to maintaining health and are also involved in various pathological conditions. Dysregulated coagulation, triggered by infection, inflammation, or tissue damage, can result in conditions such as disseminated intravascular coagulation (DIC). Concurrently, immune dysregulation may lead to coagulation disorders and thrombotic complications. This review elucidates these intricate interactions, emphasizing their roles in the pathogenesis of autoimmune diseases and cancer. Understanding the complex interplay between these systems is critical for disease management and the development of effective treatments. By exploring these common regulatory mechanisms, we can uncover innovative therapeutic strategies targeting these intricate disorders. Thus, this paper presents a comprehensive overview of the mutual interaction between the coagulation and immune systems, highlighting its significance in health maintenance and disease pathology.

摘要

凝血和免疫系统是人体中两个至关重要的系统,它们通过几个共同的调节途径紧密相连,其中包括组织因子(TF)途径。表达 TF 并产生促炎细胞因子的免疫细胞可以影响凝血,而凝血因子和过程通过激活免疫细胞并控制其功能来相互影响免疫反应。这些共同的途径有助于维持健康,也参与各种病理状况。感染、炎症或组织损伤引发的凝血失调可导致弥漫性血管内凝血(DIC)等疾病。同时,免疫失调可能导致凝血障碍和血栓并发症。本综述阐明了这些复杂的相互作用,强调了它们在自身免疫性疾病和癌症发病机制中的作用。了解这些系统之间的复杂相互作用对于疾病管理和有效治疗的发展至关重要。通过探索这些共同的调节机制,我们可以发现针对这些复杂疾病的创新治疗策略。因此,本文全面概述了凝血和免疫系统之间的相互作用,强调了它们在维持健康和疾病病理中的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/353964dacf6e/ijms-24-12563-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/772cf31ce81d/ijms-24-12563-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/51a0c75faad2/ijms-24-12563-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/82fb2df00ae4/ijms-24-12563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/0975d53137e3/ijms-24-12563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/ac062ca618b9/ijms-24-12563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/77cba6ab06e7/ijms-24-12563-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/9d180f4cc598/ijms-24-12563-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/353964dacf6e/ijms-24-12563-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/772cf31ce81d/ijms-24-12563-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/51a0c75faad2/ijms-24-12563-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/82fb2df00ae4/ijms-24-12563-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/0975d53137e3/ijms-24-12563-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/ac062ca618b9/ijms-24-12563-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/77cba6ab06e7/ijms-24-12563-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/9d180f4cc598/ijms-24-12563-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb83/10454528/353964dacf6e/ijms-24-12563-g007.jpg

相似文献

1
The Crossroads of the Coagulation System and the Immune System: Interactions and Connections.凝血系统与免疫系统的交汇点:相互作用与关联。
Int J Mol Sci. 2023 Aug 8;24(16):12563. doi: 10.3390/ijms241612563.
2
Cardiovascular disease and thrombosis: Intersections with the immune system, inflammation, and the coagulation system.心血管疾病与血栓形成:与免疫系统、炎症及凝血系统的交叉关联
Ann Pharm Fr. 2025 Mar;83(2):228-250. doi: 10.1016/j.pharma.2024.08.005. Epub 2024 Aug 17.
3
Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis.细胞因子在弥散性血管内凝血和血栓形成中的可能作用。
Baillieres Best Pract Res Clin Haematol. 1999 Sep;12(3):343-59. doi: 10.1053/beha.1999.0029.
4
Management of cancer-associated disseminated intravascular coagulation.癌症相关的弥散性血管内凝血的管理
Thromb Res. 2016 Apr;140 Suppl 1:S66-70. doi: 10.1016/S0049-3848(16)30101-3.
5
miR-19a-3p downregulates tissue factor and functions as a potential therapeutic target for sepsis-induced disseminated intravascular coagulation.miR-19a-3p 下调组织因子并作为脓毒症诱导的弥散性血管内凝血的潜在治疗靶点。
Biochem Pharmacol. 2021 Oct;192:114671. doi: 10.1016/j.bcp.2021.114671. Epub 2021 Jul 9.
6
No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.在大鼠组织因子诱导的弥散性血管内凝血中,介导凝血和炎症的途径之间不存在相互作用。
Crit Care Med. 2006 Oct;34(10):2646-50. doi: 10.1097/01.CCM.0000240228.43264.66.
7
Infection and inflammation and the coagulation system.感染、炎症与凝血系统。
Cardiovasc Res. 2003 Oct 15;60(1):26-39. doi: 10.1016/s0008-6363(02)00857-x.
8
Preliminary study of microparticle coagulation properties in septic patients with disseminated intravascular coagulation.脓毒性弥散性血管内凝血患者微粒体凝血特性的初步研究。
J Int Med Res. 2021 May;49(5):3000605211014094. doi: 10.1177/03000605211014094.
9
Regulatory role of cytokines in disseminated intravascular coagulation.细胞因子在弥散性血管内凝血中的调节作用
Semin Thromb Hemost. 2001 Dec;27(6):639-51. doi: 10.1055/s-2001-18868.
10
Coagulopathy in Severe Sepsis: Interconnectivity of Coagulation and the Immune System.严重脓毒症中的凝血功能障碍:凝血与免疫系统的相互联系
Surg Infect (Larchmt). 2018 Feb/Mar;19(2):208-215. doi: 10.1089/sur.2017.260. Epub 2018 Jan 18.

引用本文的文献

1
Identification of a coagulation-related classification and signature that predict disease heterogeneity for colorectal cancer and pan-cancer patients.鉴定一种与凝血相关的分类和特征,用于预测结直肠癌和泛癌患者的疾病异质性。
Front Immunol. 2025 Jul 24;16:1572701. doi: 10.3389/fimmu.2025.1572701. eCollection 2025.
2
The Inflammatory Link of Rheumatoid Arthritis and Thrombosis: Pathogenic Molecular Circuits and Treatment Approaches.类风湿关节炎与血栓形成的炎症关联:致病分子机制及治疗方法
Curr Issues Mol Biol. 2025 Apr 18;47(4):291. doi: 10.3390/cimb47040291.
3
The Interplay Between Autoimmune Disorders Affecting the Coagulation and Platelet Systems and Their Implications for Cardiovascular Diseases: A Systematic Review.

本文引用的文献

1
The role of monocytes in thrombotic diseases: a review.单核细胞在血栓形成性疾病中的作用:综述
Front Cardiovasc Med. 2023 Jun 2;10:1113827. doi: 10.3389/fcvm.2023.1113827. eCollection 2023.
2
Tissue factor (coagulation factor III): a potential double-edge molecule to be targeted and re-targeted toward cancer.组织因子(凝血因子III):一种有望针对癌症进行靶向及重新靶向的潜在双刃剑分子。
Biomark Res. 2023 Jun 6;11(1):60. doi: 10.1186/s40364-023-00504-6.
3
The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy.自然杀伤细胞在肿瘤转移中的作用及基于自然杀伤细胞的免疫疗法
影响凝血和血小板系统的自身免疫性疾病之间的相互作用及其对心血管疾病的影响:一项系统综述。
Cells. 2025 Jul 4;14(13):1023. doi: 10.3390/cells14131023.
4
The gut-immune axis in primary immune thrombocytopenia (ITP): a paradigm shifts in treatment approaches.原发性免疫性血小板减少症(ITP)中的肠道-免疫轴:治疗方法的范式转变
Front Immunol. 2025 Jun 12;16:1595977. doi: 10.3389/fimmu.2025.1595977. eCollection 2025.
5
The Effect of Postoperative Antithrombin Supplementation on the Inflammatory and Coagulation Status of a Surgically Treated Patient With a Malignant Tumor in the Small Pelvis-Case Series.术后补充抗凝血酶对一名接受手术治疗的小骨盆恶性肿瘤患者炎症及凝血状态的影响——病例系列
Cancer Rep (Hoboken). 2025 Jun;8(6):e70260. doi: 10.1002/cnr2.70260.
6
Incidence of, and factors associated with, oral mucous membrane medical device-related pressure injury in critically ill patients with orotracheal intubation: a prospective cohort study.经口气管插管重症患者口腔黏膜医疗器械相关压力性损伤的发生率及相关因素:一项前瞻性队列研究
BMJ Open. 2025 Jun 17;15(6):e098114. doi: 10.1136/bmjopen-2024-098114.
7
Exploring the Emerging Association Between Immune Checkpoint Inhibitors and Thrombosis.探索免疫检查点抑制剂与血栓形成之间新出现的关联。
J Clin Med. 2025 May 15;14(10):3451. doi: 10.3390/jcm14103451.
8
Exploring Proteomic Alterations in Intellectual Disability: Insights from Hyperlipidemia and Hyperphosphatasia Subgroups.探索智力障碍中的蛋白质组学改变:来自高脂血症和高磷酸酶血症亚组的见解。
Neuromolecular Med. 2025 May 20;27(1):38. doi: 10.1007/s12017-025-08855-z.
9
Molecular Mechanism of Notch Signaling and Macrophages in Deep Vein Thrombosis: A Comprehensive Review.Notch信号通路与巨噬细胞在深静脉血栓形成中的分子机制:综述
Cell Biochem Biophys. 2025 Apr 25. doi: 10.1007/s12013-025-01761-y.
10
Blood Coagulation Favors Anti-Inflammatory Immune Responses in Whole Blood.血液凝固有利于全血中的抗炎免疫反应。
Hematol Rep. 2025 Apr 11;17(2):19. doi: 10.3390/hematolrep17020019.
Cancers (Basel). 2023 Apr 16;15(8):2323. doi: 10.3390/cancers15082323.
4
Species Differences in Platelet Protease-Activated Receptors.血小板蛋白酶激活受体的种属差异。
Int J Mol Sci. 2023 May 5;24(9):8298. doi: 10.3390/ijms24098298.
5
Endothelial dysfunction and immunothrombosis in sepsis.脓毒症中的内皮功能障碍与免疫血栓形成。
Front Immunol. 2023 Apr 4;14:1144229. doi: 10.3389/fimmu.2023.1144229. eCollection 2023.
6
Towards a biomarker for acute arterial thrombosis using complete blood count and white blood cell differential parameters in mice.利用全血细胞计数和白细胞分类参数在小鼠中寻找急性动脉血栓形成的生物标志物。
Sci Rep. 2023 Mar 10;13(1):4043. doi: 10.1038/s41598-023-31122-9.
7
Sepsis-Induced Coagulopathy: An Update on Pathophysiology, Biomarkers, and Current Guidelines.脓毒症诱导的凝血病:病理生理学、生物标志物及现行指南的最新进展
Life (Basel). 2023 Jan 28;13(2):350. doi: 10.3390/life13020350.
8
Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives.免疫血栓形成:分子层面与新的治疗前景
J Clin Med. 2023 Feb 9;12(4):1399. doi: 10.3390/jcm12041399.
9
Biomarkers of Sepsis.脓毒症的生物标志物
Diagnostics (Basel). 2023 Jan 25;13(3):435. doi: 10.3390/diagnostics13030435.
10
Management Strategies in Septic Coagulopathy: A Review of the Current Literature.脓毒症凝血病的管理策略:当前文献综述
Healthcare (Basel). 2023 Jan 12;11(2):227. doi: 10.3390/healthcare11020227.